HARA KENJI

Profiles

Profiles

• 氏名

  HARA KENJI

Affiliation

• Associate Professor

Research achievements

Published Papers

Original paper
• Isolated Adrenocorticotropic Hormone Deficiency and Severe Hypercalcemia After Destructive Thyroiditis in a Patient on Nivolumab Therapy With a Malignant Melanoma, Takebayashi K, Ujiie AKubo MFurukawa SYamauchi MShinozaki HSuzuki TNaruse RHara KTsuchiya TInukai T, J Clin Med Res, 10(4), 358-362, Apr. 2018

  DOI
• Effect of canagliflozin on circulating active GLP-1 levels in patients with type 2 diabetes: a randomized trial, Takebayashi K, Hara KTerasawa TNaruse RSuetsugu MTsuchiya TInukai T, Endocr J, 64(9), 923-931, Sep. 2017

  DOI
• Serum Betatrophin Levels and Clinical Features in Patients With Poorly Controlled Type 2 Diabetes, Takebayashi K, Hara KTerasawa TNaruse RSuetsugu MTsuchiya TInukai T, J Clin Med Res, 9(9), 782-787, Sep. 2017

  DOI
• Long-Term Effect of Alogliptin on Glycemic Control in Japanese Patients With Type 2 Diabetes: A 3.5-Year Observational Study, Takebayashi K, Suzuki TNaruse RHara KSuetsugu MTsuchiya TInukai T, J Clin Med Res, 9(9), 802-808, Sep. 2017

  DOI
• Circulating SerpinB1 levels and clinical features in patients with type 2 diabetes, Takebayashi K, Hara K, Terasawa TNaruse RSuetsugu MTsuchiya TInukai T, BMJ Open Diabetes Res Care, 4(1), e000274, 2016

  DOI
• 50(3), 659-664, Dec. 2015

  DOI
• Sitagliptin, a DPP-4 inhibitor, alters the subsets of circulating CD4+ T cells in patients with type 2 diabetes, Aso Y, Fukushima MSagara MJojima TIijima TSuzuki KMomobayashi AKasai KInukai T, Diabetes Res Clin Pract, 110(3), 250-256, Dec. 2015

  DOI
• Effect of proton pump inhibitors on glycemic control in patients with diabetes, Takebayashi K, Inukai T, World J Diabetes, 6(10), 1122-1131, Aug. 2015

  DOI
• Effect of combination therapy with alogliptin and lansoprazole on glycemic control in patients with type 2 diabetes, Takebayashi K, Sakurai SSuzuki THori KTerasawa TNaruse RHara KSuetsugu MTsuchiya TAoki HHamasaki TShuutou HInukai T, Endocr J, 61(10), 1031-1039, 2014
• 91(6), 811-814, Jun. 2014
• Seasonal variations and the influence of COVID-19 pandemic on hemoglobin A1c，glycoalbumin，and low-density lipoprotein cholesterol．, Takebayashi K，Yamauchi M，Hara K，Tsuchiya T，Hashimoto K, Diabetol Int., 13(4), 599-605, Oct. 2022
• Association of skin autofluorescence with serum lipids, insulin secretion ability and diabetic complications in patients with poorly controlled type 2 diabetes., Takebayashi K, Tsuchiya T, Shinozaki H, Yamauchi M, Suzuki T, Hara K, Inukai T, Hashimoto K., Dokkyo Med J., 2022
• Switching from a dipeptidyl peptidase (DPP)-4 inhibitor to oral semaglutide in patients with poorly controlled type 2 diabetes: an observational study., Takebayashi K, Yamauchi M, Hara K, Tsuchiya T, Hashimoto K., 2022
• Analysis of five cases showing false-high Hemoglobin A1c due to reduced catalase activity., Hara K, Ujiie A, Suzuki S, Okumura T, Kubo M, Shinozaki H, Yamauchi M, Tsuchiya T, Takebayashi K, Shimozawa N, Koga M, Hashimoto K, Endocr J, 71, 39-44, 2024
• Effects of telemedicine on the management of diabetes mellitus in the COVID-19 pandemic- A single center study-., Furukawa S, Kawai S, Yamauchi M, Shinozaki H, Ujiie A, Okumura T, Kubo M, Suzuki S, Asai K, Takii H, Hara K, Miyakawa K, Hara K, Tsuchiya T, Takebayashi K, Hashimoto K, Dokkyo Med J, 2023
• Changing from a Dipeptidyl Peptidase (DPP)-4 Inhibitor to Oral Semaglutide in Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Observational Study., Takebayashi K, Yamauchi M, Hara K, Tsuchiya T, Hashimoto K., Dokkyo Medical J., 2(Jun), 123-129, 2023

Other
• Effect of Sodium Glucose Cotransporter 2 Inhibitors With Low SGLT2/SGLT1 Selectivity on Circulating Glucagon-Like Peptide 1 Levels in Type 2 Diabetes Mellitus, Takebayashi K, Inukai T, J Clin Med Res, 9(9), 745-753, Sep. 2017

  DOI

Books etc

• Single work, 2023

Educational activity

Teaching Experience

• 2015, hyperthyroidism

Social contributions

Social Contribution

• 16 Dec. 2023, 16 Dec. 2023
• 09 Apr. 2023, 09 Apr. 2023
• 02 Apr. 2024, 02 Apr. 2024
• 27 Oct. 2024, 27 Oct. 2024
• 06 Oct. 2024, 06 Oct. 2024
• 25 Aug. 2024, 25 Aug. 2024
• 13 Nov. 2022, 13 Nov. 2022
• 29 Oct. 2022, 29 Oct. 2022
• 20 Jun. 2021, 20 Jun. 2021
• 12 Dec. 2021, 12 Dec. 2021

Academic Contribution

• Apr. 2016, Apr. 2016, Not contributing to international academic